Sunshine Biopharma Inc. (SBFM) stock
SBFMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SBFMW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 10/30
$2.54−0.06 (-2.31%)
Close on Nov 17, 2026Market cap $9.85MP/E –Yield –
Sunshine Biopharma pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Sunshine Biopharma's pe ratio was 0.0× on Jan 31, 2012.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2012 | Jan 31, 2012 | 0.0× | −0.0 |
| 2011 | Dec 30, 2011 | 0.0× | – |
See a number that looks wrong?